Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aliphatic amine oxidase activity	AOC2 AOC3	5.85e-05	4	63	2	GO:0052595
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	JAK1 NEK3 PIK3C2G PIK3CB PPM1D ETNK2 FES MAP3K10 MAP3K21 ALK	6.97e-05	709	63	10	GO:0016773
GeneOntologyMolecularFunction	kinase activity	JAK1 NEK3 PIK3C2G PIK3CB PPM1D ETNK2 FES MAP3K10 MAP3K21 ALK	1.29e-04	764	63	10	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	JAK1 NEK3 RPAP1 PIK3C2G PIK3CB PPM1D ETNK2 FES MAP3K10 MAP3K21 ALK	1.52e-04	938	63	11	GO:0016772
GeneOntologyMolecularFunction	1-phosphatidylinositol-4-phosphate 3-kinase activity	PIK3C2G PIK3CB	2.04e-04	7	63	2	GO:0035005
GeneOntologyMolecularFunction	primary methylamine oxidase activity	AOC2 AOC3	3.48e-04	9	63	2	GO:0008131
GeneOntologyMolecularFunction	1-phosphatidylinositol-3-kinase activity	PIK3C2G PIK3CB	5.29e-04	11	63	2	GO:0016303
GeneOntologyMolecularFunction	protein kinase activity	JAK1 NEK3 PIK3CB PPM1D FES MAP3K10 MAP3K21 ALK	5.73e-04	600	63	8	GO:0004672
GeneOntologyMolecularFunction	JUN kinase kinase kinase activity	MAP3K10 MAP3K21	6.34e-04	12	63	2	GO:0004706
GeneOntologyMolecularFunction	N6-methyladenosine-containing RNA reader activity	IGF2BP3 IGF2BP2	1.00e-03	15	63	2	GO:1990247
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	AOC2 AOC3	1.14e-03	16	63	2	GO:0016641
GeneOntologyMolecularFunction	quinone binding	AOC2 AOC3	1.29e-03	17	63	2	GO:0048038
GeneOntologyMolecularFunction	oxidoreductase activity, acting on the CH-NH2 group of donors	AOC2 AOC3	1.79e-03	20	63	2	GO:0016638
Domain	Ser-Thr/Tyr_kinase_cat_dom	JAK1 NEK3 FES MAP3K10 MAP3K21 ALK	6.38e-06	138	62	6	IPR001245
Domain	-	AOC2 AOC3	3.25e-05	3	62	2	2.70.98.20
Domain	Cu_amine_oxidase_N3	AOC2 AOC3	3.25e-05	3	62	2	IPR015802
Domain	Cu_amine_oxidase_N2	AOC2 AOC3	3.25e-05	3	62	2	IPR015800
Domain	Cu_amine_oxidN2	AOC2 AOC3	3.25e-05	3	62	2	PF02727
Domain	Cu_amine_oxidN3	AOC2 AOC3	3.25e-05	3	62	2	PF02728
Domain	Cu_amine_oxidase_N-reg	AOC2 AOC3	3.25e-05	3	62	2	IPR016182
Domain	Cu_amine_oxid	AOC2 AOC3	3.25e-05	3	62	2	PF01179
Domain	Cu_amine_oxidase_C	AOC2 AOC3	3.25e-05	3	62	2	IPR015798
Domain	COPPER_AMINE_OXID_1	AOC2 AOC3	3.25e-05	3	62	2	PS01164
Domain	COPPER_AMINE_OXID_2	AOC2 AOC3	3.25e-05	3	62	2	PS01165
Domain	MLK1/MLK2/MLK4	MAP3K10 MAP3K21	6.48e-05	4	62	2	IPR016231
Domain	MAP3K10	MAP3K10 MAP3K21	6.48e-05	4	62	2	IPR015785
Domain	Cu_amine_oxidase	AOC2 AOC3	6.48e-05	4	62	2	IPR000269
Domain	Pkinase_Tyr	JAK1 FES MAP3K10 MAP3K21 ALK	6.86e-05	129	62	5	PF07714
Domain	Kinase-like_dom	JAK1 NEK3 PIK3C2G PIK3CB ETNK2 FES MAP3K10 MAP3K21 ALK	7.04e-05	542	62	9	IPR011009
Domain	TyrKc	JAK1 FES MAP3K21 ALK	2.08e-04	88	62	4	SM00219
Domain	Tyr_kinase_cat_dom	JAK1 FES MAP3K21 ALK	2.08e-04	88	62	4	IPR020635
Domain	PI3K_Ras-bd_dom	PIK3C2G PIK3CB	2.25e-04	7	62	2	IPR000341
Domain	PI3K_rbd	PIK3C2G PIK3CB	2.25e-04	7	62	2	PF00794
Domain	PI3K_RBD	PIK3C2G PIK3CB	2.25e-04	7	62	2	PS51546
Domain	PI3K_rbd	PIK3C2G PIK3CB	2.25e-04	7	62	2	SM00144
Domain	PI3K_C2_dom	PIK3C2G PIK3CB	3.00e-04	8	62	2	IPR002420
Domain	PI3K_C2	PIK3C2G PIK3CB	3.00e-04	8	62	2	PF00792
Domain	PI3K_C2	PIK3C2G PIK3CB	3.00e-04	8	62	2	PS51547
Domain	PI3K_C2	PIK3C2G PIK3CB	3.00e-04	8	62	2	SM00142
Domain	PI3Ka	PIK3C2G PIK3CB	3.85e-04	9	62	2	PF00613
Domain	-	PIK3C2G PIK3CB	3.85e-04	9	62	2	1.25.40.70
Domain	PI3Ka	PIK3C2G PIK3CB	3.85e-04	9	62	2	SM00145
Domain	PIK_HELICAL	PIK3C2G PIK3CB	4.80e-04	10	62	2	PS51545
Domain	PI_Kinase	PIK3C2G PIK3CB	4.80e-04	10	62	2	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3C2G PIK3CB	4.80e-04	10	62	2	IPR001263
Domain	PI3/4_kinase_CS	PIK3C2G PIK3CB	1.11e-03	15	62	2	IPR018936
Domain	-	PIK3C2G PIK3CB	1.26e-03	16	62	2	1.10.1070.11
Domain	PI3Kc	PIK3C2G PIK3CB	1.26e-03	16	62	2	SM00146
Domain	-	PIK3C2G PIK3CB SYT1 NEDD4	1.48e-03	148	62	4	2.60.40.150
Domain	Protein_kinase_ATP_BS	JAK1 NEK3 FES MAP3K10 MAP3K21 ALK	1.58e-03	379	62	6	IPR017441
Domain	PI3/4_kinase_cat_dom	PIK3C2G PIK3CB	1.60e-03	18	62	2	IPR000403
Domain	PI3_PI4_kinase	PIK3C2G PIK3CB	1.60e-03	18	62	2	PF00454
Domain	PI3_4_KINASE_3	PIK3C2G PIK3CB	1.60e-03	18	62	2	PS50290
Domain	PI3_4_KINASE_1	PIK3C2G PIK3CB	1.60e-03	18	62	2	PS00915
Domain	PI3_4_KINASE_2	PIK3C2G PIK3CB	1.60e-03	18	62	2	PS00916
Domain	C2_dom	PIK3C2G PIK3CB SYT1 NEDD4	2.15e-03	164	62	4	IPR000008
Domain	PROTEIN_KINASE_ATP	JAK1 NEK3 FES MAP3K10 MAP3K21 ALK	4.10e-03	459	62	6	PS00107
Domain	PROTEIN_KINASE_TYR	JAK1 FES ALK	4.11e-03	97	62	3	PS00109
Domain	Tyr_kinase_AS	JAK1 FES ALK	4.11e-03	97	62	3	IPR008266
Domain	Prot_kinase_dom	JAK1 NEK3 FES MAP3K10 MAP3K21 ALK	5.56e-03	489	62	6	IPR000719
Domain	PROTEIN_KINASE_DOM	JAK1 NEK3 FES MAP3K10 MAP3K21 ALK	5.79e-03	493	62	6	PS50011
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CRYBG2 ERCC2 PDE4A MAN2B1 RPAP1 CCDC34 AOC2 SEC16A PEX6 PCNX1 GGA1 CRAMP1 IGSF3	7.52e-08	1105	63	13	35748872
Pubmed	A network of heterochronic genes including Imp1 regulates temporal changes in stem cell properties.	IGF2BP3 IGF2BP2 APC SYT1	3.38e-07	32	63	4	24192035
Pubmed	Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.	IGF2BP3 IGF2BP2 ZMYND8 APC	1.14e-06	43	63	4	36950384
Pubmed	Genomic analysis of mouse retinal development.	CLIP3 RAB3GAP1 IGF2BP3 ERCC2 CHST14 PIK3C2G SCG2 APC SYT1 RPL15 NEDD4	1.75e-06	1006	63	11	15226823
Pubmed	Associations of schizophrenia risk genes ZNF804A and CACNA1C with schizotypy and modulation of attention in healthy subjects.	CACNA1C ZNF804A	3.23e-06	2	63	2	31076262
Pubmed	The impact of CACNA1C gene, and its epistasis with ZNF804A, on white matter microstructure in health, schizophrenia and bipolar disorder1.	CACNA1C ZNF804A	3.23e-06	2	63	2	27790829
Pubmed	GGA function is required for maturation of neuroendocrine secretory granules.	SCG2 GGA1	3.23e-06	2	63	2	16601685
Pubmed	Impact of ZNF804A rs1344706 or CACNA1C rs1006737 polymorphisms on cognition in patients with severe mental disorders: A systematic review and meta-analysis.	CACNA1C ZNF804A	3.23e-06	2	63	2	35786202
Pubmed	The unique substrate specificity of human AOC2, a semicarbazide-sensitive amine oxidase.	AOC2 AOC3	3.23e-06	2	63	2	19588076
Pubmed	Neuronal precursor cell-expressed developmentally down-regulated 4-1 (NEDD4-1) controls the sorting of newly synthesized Ca(V)1.2 calcium channels.	CACNA1C NEDD4	3.23e-06	2	63	2	21220429
Pubmed	Anatomical distribution of primary amine oxidase activity in four adipose depots and plasma of severely obese women with or without a dysmetabolic profile.	AOC2 AOC3	3.23e-06	2	63	2	27766585
Pubmed	The effect of psychosis associated CACNA1C, and its epistasis with ZNF804A, on brain function.	CACNA1C ZNF804A	3.23e-06	2	63	2	30079586
Pubmed	A functional neuroimaging association study on the interplay between two schizophrenia genome-wide associated genes (CACNA1C and ZNF804A).	CACNA1C ZNF804A	3.23e-06	2	63	2	35796825
Pubmed	Intestinal knockout of Nedd4 enhances growth of Apcmin tumors.	APC NEDD4	3.23e-06	2	63	2	27086928
Pubmed	HIV-1 Tat protein induces the production of IDO in human monocyte derived-dendritic cells through a direct mechanism: effect on T cells proliferation.	JAK1 PIK3C2G PIK3CB	5.38e-06	19	63	3	24073214
Pubmed	IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	20627640
Pubmed	Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	17296566
Pubmed	Hematopoietic prostaglandin D synthase suppresses intestinal adenomas in ApcMin/+ mice.	HPGDS APC	9.68e-06	3	63	2	17283118
Pubmed	Fes mediates the IL-4 activation of insulin receptor substrate-2 and cellular proliferation.	JAK1 FES	9.68e-06	3	63	2	11160325
Pubmed	IMP2 and IMP3 cooperate to promote the metastasis of triple-negative breast cancer through destabilization of progesterone receptor.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	29217458
Pubmed	Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	29476152
Pubmed	Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	16049158
Pubmed	A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	9891060
Pubmed	m6A-dependent upregulation of DDX21 by super-enhancer-driven IGF2BP2 and IGF2BP3 facilitates progression of acute myeloid leukaemia.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	38572589
Pubmed	VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	15601260
Pubmed	Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	32668274
Pubmed	Wip1 phosphatase regulates p53-dependent apoptosis of stem cells and tumorigenesis in the mouse intestine.	PPM1D APC	9.68e-06	3	63	2	18371349
Pubmed	Characterization of AOC2 gene encoding a copper-binding amine oxidase expressed specifically in retina.	AOC2 AOC3	9.68e-06	3	63	2	14585497
Pubmed	ZBP1 recognition of beta-actin zipcode induces RNA looping.	IGF2BP3 IGF2BP2	9.68e-06	3	63	2	20080952
Pubmed	ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype.	CACNA1C ZNF804A	9.68e-06	3	63	2	21767209
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	IGF2BP3 CD5 STON1 SEC16A APC MRPS9 GGA1 IGSF3 RPL15	1.07e-05	777	63	9	35844135
Pubmed	HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway.	PDE4A PIK3C2G PIK3CB	1.61e-05	27	63	3	11156964
Pubmed	The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing.	IGF2BP3 IGF2BP2	1.93e-05	4	63	2	27184842
Pubmed	Kir5.1 regulates Nedd4-2-mediated ubiquitination of Kir4.1 in distal nephron.	KCNJ16 NEDD4	1.93e-05	4	63	2	29897283
Pubmed	H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein.	IGF2BP3 IGF2BP2	1.93e-05	4	63	2	10875929
Pubmed	The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerability.	ZMYND8 APC	1.93e-05	4	63	2	33932349
Pubmed	Phosphodiesterase 4B in the cardiac L-type Ca²⁺ channel complex regulates Ca²⁺ current and protects against ventricular arrhythmias in mice.	CACNA1C PDE4A	1.93e-05	4	63	2	21670503
Pubmed	Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colon.	PPM1D APC	1.93e-05	4	63	2	31659152
Pubmed	mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry.	IGF2BP3 IGF2BP2	1.93e-05	4	63	2	21576258
Pubmed	Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2.	IGF2BP3 IGF2BP2	1.93e-05	4	63	2	15225648
Pubmed	miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma.	IGF2BP3 IGF2BP2	1.93e-05	4	63	2	26160756
Pubmed	IMP2 axonal localization, RNA interactome, and function in the development of axon trajectories.	IGF2BP3 IGF2BP2	1.93e-05	4	63	2	27385015
Pubmed	Functional dissection of the interactions of stonin 2 with the adaptor complex AP-2 and synaptotagmin.	STON1 SYT1	1.93e-05	4	63	2	14726597
Pubmed	Human stoned B interacts with AP-2 and synaptotagmin and facilitates clathrin-coated vesicle uncoating.	STON1 SYT1	3.22e-05	5	63	2	11454741
Pubmed	Multiple modification and protein interaction signals drive the Ring finger protein 11 (RNF11) E3 ligase to the endosomal compartment.	GGA1 NEDD4	4.82e-05	6	63	2	20676133
Pubmed	Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-25, and synaptotagmin.	CACNA1C SYT1	4.82e-05	6	63	2	11438518
Pubmed	circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity.	IGF2BP3 IGF2BP2	4.82e-05	6	63	2	33436560
Pubmed	The application of the polymerase chain reaction to cloning members of the protein tyrosine kinase family.	JAK1 FES	6.74e-05	7	63	2	2482828
Pubmed	IL-4/IL-13 signaling beyond JAK/STAT.	JAK1 FES	6.74e-05	7	63	2	10856136
Pubmed	Stonin 2: an adaptor-like protein that interacts with components of the endocytic machinery.	STON1 SYT1	8.98e-05	8	63	2	11381094
Pubmed	METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression.	IGF2BP3 IGF2BP2	1.15e-04	9	63	2	37340443
Pubmed	Role of Gadd45a in Wip1-dependent regulation of intestinal tumorigenesis.	PPM1D APC	1.15e-04	9	63	2	22555459
Pubmed	The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1.	PIK3C2G PIK3CB	1.44e-04	10	63	2	8636073
Pubmed	Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells.	PIK3C2G PIK3CB	1.44e-04	10	63	2	8798481
Pubmed	CAPS1 regulates catecholamine loading of large dense-core vesicles.	SCG2 SYT1	1.44e-04	10	63	2	15820695
Pubmed	Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity.	PIK3C2G PIK3CB	1.44e-04	10	63	2	9247029
Pubmed	Two dominant host resistance genes to pre-B lymphoma in wild-derived inbred mouse strain MSM/Ms.	APC CFB	1.44e-04	10	63	2	8706013
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	RPAP1 PCDH11X CRAMP1 DNAH1	1.75e-04	153	63	4	10718198
Pubmed	HIV-1 gp120-induced TNF-{alpha} production by primary human macrophages is mediated by phosphatidylinositol-3 (PI-3) kinase and mitogen-activated protein (MAP) kinase pathways.	PIK3C2G PIK3CB	1.76e-04	11	63	2	16081599
Pubmed	HIV-1 Tat induces tyrosine phosphorylation of p125FAK and its association with phosphoinositide 3-kinase in PC12 cells.	PIK3C2G PIK3CB	1.76e-04	11	63	2	9708406
Pubmed	HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line.	PIK3C2G PIK3CB	1.76e-04	11	63	2	10985305
Pubmed	Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells.	PIK3C2G PIK3CB	1.76e-04	11	63	2	12584329
Pubmed	Ligands of CD4 inhibit the association of phospholipase Cgamma1 with phosphoinositide 3 kinase in T cells: regulation of this association by the phosphoinositide 3 kinase activity.	PIK3C2G PIK3CB	1.76e-04	11	63	2	9808187
Pubmed	Cold-inducible RBM3 inhibits PERK phosphorylation through cooperation with NF90 to protect cells from endoplasmic reticulum stress.	IGF2BP3 IGF2BP2 MRPS9	1.80e-04	60	63	3	26472337
Pubmed	Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.	PIK3C2G PIK3CB	2.11e-04	12	63	2	14602571
Pubmed	Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells.	PIK3C2G PIK3CB	2.11e-04	12	63	2	16514418
Pubmed	HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes.	PIK3C2G PIK3CB	2.11e-04	12	63	2	10208934
Pubmed	Recruitment of phosphatidylinositol 3-kinase to CD28 inhibits HIV transcription by a Tat-dependent mechanism.	PIK3C2G PIK3CB	2.11e-04	12	63	2	12077252
Pubmed	Down-regulation of LFA-1-mediated T cell adhesion induced by the HIV envelope glycoprotein gp160 requires phosphatidylinositol-3-kinase activity.	PIK3C2G PIK3CB	2.11e-04	12	63	2	9341793
Pubmed	Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages.	PIK3C2G PIK3CB	2.11e-04	12	63	2	12551992
Pubmed	HIV-1 Nef in macrophage-mediated disease pathogenesis.	PIK3C2G PIK3CB	2.49e-04	13	63	2	23215766
Pubmed	Genotype phenotype correlations in Israeli colorectal cancer patients.	ERCC2 APC	2.49e-04	13	63	2	15523694
Pubmed	Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells.	PIK3C2G PIK3CB	2.49e-04	13	63	2	9394803
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	RAB3GAP1 IGF2BP3 ERCC2 IGF2BP2 RPAP1 ZMYND8 MRPS9	2.80e-04	704	63	7	29955894
Pubmed	Neurocalcin Delta Knockout Impairs Adult Neurogenesis Whereas Half Reduction Is Not Pathological.	APC MAP3K10	2.90e-04	14	63	2	30853885
Pubmed	Infection of human immunodeficiency virus and intracellular viral Tat protein exert a pro-survival effect in a human microglial cell line.	PIK3C2G PIK3CB	2.90e-04	14	63	2	17157319
Pubmed	HIV Nef enhances Tat-mediated viral transcription through a hnRNP-K-nucleated signaling complex.	PIK3C2G PIK3CB	3.34e-04	15	63	2	18854243
Pubmed	Zbtb7b engages the long noncoding RNA Blnc1 to drive brown and beige fat development and thermogenesis.	JAK1 NEDD4	3.34e-04	15	63	2	28784777
Pubmed	HIV-1 gp120-mediated apoptosis of T cells is regulated by the membrane tyrosine phosphatase CD45.	PIK3C2G PIK3CB	3.81e-04	16	63	2	16524887
Pubmed	HIV-1 Nef blocks transport of MHC class I molecules to the cell surface via a PI 3-kinase-dependent pathway.	PIK3C2G PIK3CB	3.81e-04	16	63	2	11289809
Pubmed	Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice.	PIK3C2G PIK3CB	3.81e-04	16	63	2	20019835
Pubmed	Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.	PIK3C2G PIK3CB	3.81e-04	16	63	2	21029719
Pubmed	A high-throughput candidate gene mutation screen in lymphoproliferative and myeloproliferative neoplasias.	JAK1 FES	3.81e-04	16	63	2	19464057
Pubmed	Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders.	PIK3C2G PIK3CB	3.81e-04	16	63	2	20818790
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	JAK1 CRNKL1 PPM1D ZMYND8 PARL	3.88e-04	341	63	5	32971831
Pubmed	Synergistic cooperation between methamphetamine and HIV-1 gsp120 through the P13K/Akt pathway induces IL-6 but not IL-8 expression in astrocytes.	PIK3C2G PIK3CB	4.32e-04	17	63	2	23251686
Pubmed	Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways.	PIK3C2G PIK3CB	4.32e-04	17	63	2	12960231
Pubmed	Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages.	PIK3C2G PIK3CB	4.32e-04	17	63	2	18453587
Pubmed	Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes.	CD5 CHRM5	4.32e-04	17	63	2	10549128
Pubmed	SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes.	JAK1 IGF2BP3 SEC16A APC RPL15	4.54e-04	353	63	5	27545878
Pubmed	The protein tyrosine kinase family of the human genome.	JAK1 FES ALK	4.69e-04	83	63	3	11114734
Pubmed	HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway.	PIK3C2G PIK3CB	4.85e-04	18	63	2	12526811
Pubmed	Genetically distinct subsets within ANCA-associated vasculitis.	MXRA5 PCDH11X	4.85e-04	18	63	2	22808956
Pubmed	EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes.	IGF2BP2 RPL15	4.85e-04	18	63	2	15064750
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	JAK1 CRNKL1 SCG2 ZMYND8 APC MRPS9 MAP3K10 GEN1 RPL15	4.90e-04	1285	63	9	35914814
Pubmed	Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays.	AMPD2 FES SYT1 NEDD4	5.13e-04	203	63	4	19953087
Pubmed	No evidence for association between 19 cholinergic genes and bipolar disorder.	CHRM5 CHRNB1	5.41e-04	19	63	2	17373692
Pubmed	Large-scale concatenation cDNA sequencing.	CACNA1C AOC3 PCDH11X APC ZNF804A RPL15	5.71e-04	568	63	6	9110174
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	IGF2BP3 STON1 SEC16A APC	5.72e-04	209	63	4	36779422
Pubmed	Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.	PIK3C2G PIK3CB	6.63e-04	21	63	2	9446795
Cytoband	Ensembl 112 genes in cytogenetic band chr15q15	RPAP1 CHST14 RHOV	1.11e-03	147	63	3	chr15q15
Cytoband	15q15.1	RPAP1 CHST14	1.93e-03	47	63	2	15q15.1
Cytoband	3p21.3	VILL DLEC1	3.02e-03	59	63	2	3p21.3
Cytoband	17q21	AOC2 AOC3	3.43e-03	63	63	2	17q21
GeneFamily	Phosphatidylinositol 3-kinase subunits	PIK3C2G PIK3CB	1.68e-04	8	45	2	831
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	MAP3K10 MAP3K21	1.61e-03	24	45	2	654
ToppCell	wk_15-18-Epithelial-PNS-KCNIP4+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	5.50e-06	179	63	5	e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a
ToppCell	wk_15-18-Epithelial-PNS-SST+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	5.96e-06	182	63	5	a7e77aaaddabf78c7784f72b3431703fc5ee4a8c
ToppCell	wk_15-18-Epithelial-PNS-PCP4+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	7.16e-06	189	63	5	22c927d2691b867fbdee1fbee042a6d3f7eadd7d
ToppCell	wk_08-11-Epithelial-PNS-SST+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	7.53e-06	191	63	5	df2bef74a54f4c23c99bd3b93225fd36bcd90723
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SCG2 SYT1 ZNF804A ALK	7.53e-06	191	63	5	73b15ffa60d592c43aaa575f1b1479d49a66dfe8
ToppCell	wk_08-11-Epithelial-PNS-KCNIP4+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	7.72e-06	192	63	5	53642c88891f4e4e14b1740c5ced759b7d8b3572
ToppCell	wk_15-18-Epithelial-PNS\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	7.92e-06	193	63	5	ca65f8f93058ad50d89e69e06c10deeb46dbfc87
ToppCell	Thalamus-Neuronal\|Thalamus / BrainAtlas - Mouse McCarroll V32	RAB3GAP1 GPR22 RHOV SCG2 SYT1	7.92e-06	193	63	5	712a4acd1167e43543950bc819ff11984e6f718d
ToppCell	18-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	GPR22 SCG2 SYT1 ZNF804A ALK	8.12e-06	194	63	5	d3c90e1f1228f8ba0ba56105c6cf4f302c388f28
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SCG2 SYT1 ZNF804A ALK	8.75e-06	197	63	5	a1ae1aa797762a3768e14434c7e5cd19c595ecb3
ToppCell	wk_08-11-Epithelial-PNS\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	8.75e-06	197	63	5	ce3f9feb6935f0e9daf13673b0a0d6e92817e187
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SCG2 SYT1 ZNF804A ALK	8.75e-06	197	63	5	5593721407f61fc5bc3f2f8bf8fa2604c4e29565
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	CRYBG2 IQCH VILL DLEC1 DNAH1	8.97e-06	198	63	5	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	CRYBG2 IQCH VILL DLEC1 DNAH1	8.97e-06	198	63	5	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	wk_08-11-Epithelial-PNS-TM4SF4+_CHODL+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ZNF804A ALK	8.97e-06	198	63	5	eb3c389e7452d74e5e15179503e480d6d11ca9ca
ToppCell	MS-Multiple_Sclerosis-Others-HSPC\|Multiple_Sclerosis / Disease, condition lineage and cell class	IGF2BP2 HPGDS KBTBD12 ZNF804A NEDD4	9.19e-06	199	63	5	7f4a22207a8b27af9a070d289e31ebd0e57af1a6
ToppCell	TCGA-Peripheral_Nervous_System\|World / Sample_Type by Project: Shred V9	AMPD2 GPR22 SCG2 SYT1	5.18e-05	144	63	4	3bbadb4b07ffb461d5400a5d69ad3b259f74041e
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	STON1 PIK3C2G KCNJ16 CFB	6.39e-05	152	63	4	eee86b508b8f140ea44e21d8c04c409a7b689e39
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3CB KCNJ16 GEN1 CHRNB1	6.39e-05	152	63	4	b61d2f6ee819c8dd4b4b601a8bc8388b1983de58
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IQCH IQCC DLEC1 DNAH1	6.72e-05	154	63	4	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IQCH IQCC DLEC1 DNAH1	6.72e-05	154	63	4	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|lymph-node_spleen / Manually curated celltypes from each tissue	ERCC2 PDE4A IQCC GEN1	6.89e-05	155	63	4	b0e456c4915076e1d38282e116a6eb3230ae80dc
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGF2BP2 IQCC PIK3CB KCNJ16	7.42e-05	158	63	4	d3446fc98eff09c3626b47a2c90d07cd985378b5
ToppCell	droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGF2BP2 IQCC PIK3CB KCNJ16	7.42e-05	158	63	4	df614450e10629dc9115d7365397663e82f9e48f
ToppCell	droplet-Lung-nan-18m-Lymphocytic-plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBG2 TP53INP1 SYT1 GEN1	8.37e-05	163	63	4	5efecdd8a069a822bc9d35b407092925a865e629
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Undetermined\|Myeloid_cells / Location, Cell class and cell subclass	MXRA5 HPGDS RHOV RPL15	8.37e-05	163	63	4	be774c0ba38fa89a9c0076524cf05d593c6c6826
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Plasma_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBG2 TP53INP1 SYT1 GEN1	8.37e-05	163	63	4	0d94a427f86e62aba12c397c6d7b8cd297f3a0e5
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBG2 TP53INP1 SYT1 GEN1	8.57e-05	164	63	4	b92e7c91910d518627376166c6ea9ed333b3d07e
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-plasma_cell-plasma_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CRYBG2 TP53INP1 SYT1 GEN1	8.57e-05	164	63	4	a1e43c6b3e2553f5604100db6e92bf244b70c36d
ToppCell	facs-Skin-Anagen-24m-Epithelial-epidermal_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBG2 PIK3C2G RHOV CHRM5	9.20e-05	167	63	4	02c89069dcd0e87f7502e32b14e7cbd3cab81a09
ToppCell	Posterior_cortex-Neuronal-Inhibitory\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	SCG2 ZNF804A ALK IGSF3	9.20e-05	167	63	4	9a84f45345c75f2c8ff38a04245aadee2a26a240
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MXRA5 SCG2 ZNF804A IGSF3	1.08e-04	174	63	4	fdadac1eaab2c4a67e4832f0901df22e893add6a
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR22 RHOV SCG2 ZNF804A	1.10e-04	175	63	4	19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51
ToppCell	PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_NA\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 ZNF804A ALK	1.15e-04	177	63	4	8c78f7de091f16e86e326a73c9f1429e0232821f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SCG2 ZNF804A ALK NEDD4	1.20e-04	179	63	4	3b0f8781232e1d42b6f8913bc989a14b3f978e79
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SCG2 ZNF804A ALK NEDD4	1.25e-04	181	63	4	153709b4dd3d81e09f251fa8765b58bed1932fda
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	CD5 PIK3CB CCDC34 DNAH1	1.28e-04	182	63	4	03992d0ae519795239e4f2cc8e63f33c4482de6a
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HPGDS RHOV MAP3K10 CRAMP1	1.28e-04	182	63	4	57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 PIK3C2G RHOV RPL15	1.34e-04	184	63	4	9690d4290e70f9bda889754ffb30b0af1f7cb94b
ToppCell	PCW_13-14-Neuronal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 ZNF804A ALK	1.34e-04	184	63	4	65cf3460125e3dbc34978957bc138a449f71f7df
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR22 SCG2 SYT1 ZNF804A	1.34e-04	184	63	4	3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff
ToppCell	PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GPR22 SCG2 SYT1 ZNF804A	1.34e-04	184	63	4	1e2f0cec50475a1cf2973a5082826bbc60fc9a68
ToppCell	COVID-19_Moderate-HSPC\|World / disease group, cell group and cell class	CLIP3 IGF2BP2 HPGDS NEDD4	1.34e-04	184	63	4	ccc93babe1fcdeb66b78e1d8414357877a7c45bd
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TP53INP1 SYT1 ZNF804A CHRNB1	1.36e-04	185	63	4	238938a4682b44e88a30b86b13af4feeabe9553d
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CLIP3 SYT1 PZP	1.39e-04	186	63	4	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ALK	1.39e-04	186	63	4	72f7427d62d65e37bb0bf99229a1b75df081a128
ToppCell	PCW_07-8.5-Neuronal-Neuronal_postreplicative\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 ZNF804A ALK	1.39e-04	186	63	4	2fdd0a80ad31cf017aafcf5dcf760ebd786b98c1
ToppCell	PCW_13-14-Neuronal-Neuronal_postreplicative\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 ZNF804A ALK	1.39e-04	186	63	4	cf96f880e6e22189593ce1357c55e65c34644559
ToppCell	PCW_07-8.5-Neuronal\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 ZNF804A ALK	1.39e-04	186	63	4	7a4bb42f3f6a27b463e48eafc587d9ab3386f2fb
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 PIK3C2G RHOV MAP3K21	1.39e-04	186	63	4	b3358e0fa6d845c81e94d56c8575f016621d28ff
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	IGF2BP3 ERCC2 VILL SEC16A	1.42e-04	187	63	4	3c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	RHOV SCG2 SYT1 CHRM5	1.45e-04	188	63	4	b73e8a40393c3f656e2fcfe395a761b1f985c254
ToppCell	PCW_07-8.5-Neuronal-Neuronal_postreplicative-neuro_immature_neuronal_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 ZNF804A ALK	1.48e-04	189	63	4	de06ef69f3f97b3f21dc269eb6965da9b2f6e3f8
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CLIP3 SYT1 PZP	1.54e-04	191	63	4	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	RHOV SCG2 SYT1 ZNF804A	1.54e-04	191	63	4	5d24022cec293bc8d9e978ae99a109e660bb8f83
ToppCell	Entopeduncular-Neuronal-Inhibitory\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	RHOV SCG2 SYT1 ZNF804A	1.54e-04	191	63	4	73dae4cdea86aec62393ad7303dc7375a6b3fc86
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CACNA1C CLIP3 SYT1 ZNF804A	1.54e-04	191	63	4	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SCG2 SYT1 ALK	1.57e-04	192	63	4	d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5
ToppCell	11.5-Airway-Epithelial-Epithelial\|Airway / Age, Tissue, Lineage and Cell class	GPR22 SCG2 ZNF804A ALK	1.57e-04	192	63	4	a77d3692ff02ef7e066a9bd9e22725055a25c4d4
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SCG2 SYT1 ZNF804A	1.57e-04	192	63	4	2f1c4ef693515ccc7231bd8c6641fad51d445d20
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPR22 CCDC34 PCDH11X SYT1	1.57e-04	192	63	4	f518839ecd9377537a414e8798766f7d91eafeac
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SCG2 SYT1 ALK	1.60e-04	193	63	4	9661ea0ee7273928c7de2a9f49e853595fa77699
ToppCell	LAM-LAM-LAM+\|LAM / Condition, Lineage and Cell class	CACNA1C CLIP3 GPR22 SYT1	1.64e-04	194	63	4	4ba73a9145ed44896e359f6df9c1f32bbe24a189
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SCG2 SYT1 ALK	1.64e-04	194	63	4	5bd0f739aa75f387cca7c3b2686493ee2d1ee968
ToppCell	LAM-LAM\|LAM / Condition, Lineage and Cell class	CACNA1C CLIP3 GPR22 SYT1	1.64e-04	194	63	4	4c6561a64711c72c4ef4a3e67c41d2e8d31fba57
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JAK1 HPGDS SCG2 APC	1.67e-04	195	63	4	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	15-Trachea-Epithelial-Epithelial\|Trachea / Age, Tissue, Lineage and Cell class	CLIP3 GPR22 SYT1 ZNF804A	1.67e-04	195	63	4	9e9283a397f56732a0a5f2e2527f154d4c2dd56a
ToppCell	wk_08-11-Epithelial-PNS-TM4SF4+_PENK+_neuron\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	GPR22 SCG2 SYT1 ALK	1.70e-04	196	63	4	afa3a2f5f3a51d1830c6f95f97a4b3e13ed42512
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPR22 SYT1 ZNF804A ALK	1.77e-04	198	63	4	6483d412b6c0aab58b3348f99231caa5daf65025
ToppCell	Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C PIK3C2G AOC3 CRAMP1	1.77e-04	198	63	4	882710bd6215e299257dd3df234292db9a2823ba
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 PIK3C2G KCNJ16 CFB	1.77e-04	198	63	4	0d9d401190792fd61434f1b82548253187d805f0
ToppCell	Fetal_29-31_weeks\|World / Lineage, Cell type, age group and donor	CACNA1C IGF2BP3 IGF2BP2 RPL15	1.80e-04	199	63	4	5b9d355795dd03a22f0961dfd143425c367a4654
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	GPR22 SCG2 APC SYT1	1.80e-04	199	63	4	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	COVID-19-COVID-19_Severe-Others-HSPC\|COVID-19_Severe / Disease, condition lineage and cell class	CLIP3 IGF2BP2 HPGDS NEDD4	1.80e-04	199	63	4	25de67b6c9c8d6bb9a538e071a40ef865906c95d
ToppCell	LPS_anti-TNF-Epithelial_airway-airway_epithelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	IQCH VILL DLEC1 DNAH1	1.80e-04	199	63	4	60919c2af31d39a2d36d7bc432e43dab2a4e05fb
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6\|World / Primary Cells by Cluster	GPR22 PCDH11X APC RPL15	1.80e-04	199	63	4	1b1bccf4293f11048709d15a3c892c0edf3da3d2
ToppCell	COVID-19-COVID-19_Mild-Others-HSPC\|COVID-19_Mild / Disease, condition lineage and cell class	CLIP3 IGF2BP2 HPGDS NEDD4	1.80e-04	199	63	4	0230103c37ae3aff58240739b89f2c36b1e39a69
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal\|World / Primary Cells by Cluster	GPR22 PCDH11X APC RPL15	1.80e-04	199	63	4	4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f
ToppCell	LPS_anti-TNF-Epithelial_airway\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	IQCH VILL DLEC1 DNAH1	1.80e-04	199	63	4	6aca164bbbb961f34b1e6f1857f91ade5c059405
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 PIK3C2G KCNJ16 MAP3K21	1.80e-04	199	63	4	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	IQCH PIK3C2G DLEC1 DNAH1	1.84e-04	200	63	4	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	IQCH VILL DLEC1 DNAH1	1.84e-04	200	63	4	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	Parenchymal-10x5prime-Stromal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CACNA1C CLIP3 MXRA5 AOC3	1.84e-04	200	63	4	2e525c0d9684e7a2275edb04e1addb6fc6a872e5
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MXRA5 SCG2 ZNF804A IGSF3	1.84e-04	200	63	4	e1fca7ee2dc18c7fded53c3561f519c1fcd9767a
ToppCell	Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CACNA1C CLIP3 MXRA5 STON1	1.84e-04	200	63	4	16a3685c41194a0a4a772e4eee372160263480e0
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	JAK1 IGF2BP3 IGF2BP2 NEDD4	1.84e-04	200	63	4	3585484c7e24e941708bee471ca607d8ccee74e6
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Interneuron\|5w / Sample Type, Dataset, Time_group, and Cell type.	GPR22 APC SYT1 IGSF3	1.84e-04	200	63	4	c7e33057466915d4e2b34f2062b22d9cdffa69dc
ToppCell	Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-ADAMTSL1-L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	MXRA5 SCG2 ZNF804A IGSF3	1.84e-04	200	63	4	4409471479dd7c0f770bcb84ba7b3652c4706743
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	IQCH VILL DLEC1 DNAH1	1.84e-04	200	63	4	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
Drug	Nsc82118	AOC2 AOC3 CFB	2.01e-07	5	63	3	CID000164749
Drug	ethylglyoxal	AOC2 AOC3 CFB	4.01e-07	6	63	3	CID000145744
Drug	AC1L3Y6U	AOC2 AOC3 CFB	7.01e-07	7	63	3	CID000097282
Drug	Drotaverine	CACNA1C PDE4A	7.54e-06	2	63	2	DB06751
Drug	diphenylglyoxal bis(guanylhydrazone	AOC2 AOC3	7.54e-06	2	63	2	CID000357080
Drug	AC1Q77R6	AOC2 AOC3	7.54e-06	2	63	2	CID000094259
Drug	DPGBG	AOC2 AOC3	7.54e-06	2	63	2	CID005356884
Drug	monopropionylcadaverine	AOC2 AOC3	7.54e-06	2	63	2	CID000194207
Drug	p-dimethylaminomethylbenzaldehyde	AOC2 AOC3	7.54e-06	2	63	2	CID000193251
Drug	1-carboxymethylpyridinium	AOC2 AOC3	7.54e-06	2	63	2	CID000080439
Drug	isoputreanine	AOC2 AOC3	7.54e-06	2	63	2	CID000171763
Drug	supinidine	AOC2 AOC3	7.54e-06	2	63	2	CID000164663
Drug	N-(3-aminopropyl)pyrrolidin-2-one	AOC2 AOC3	7.54e-06	2	63	2	CID000082111
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	CRYBG2 MXRA5 STON1 IQCC SCG2 BBS9	1.35e-05	188	63	6	3177_UP
Drug	2-bromoethylamine	AOC2 AOC3 ALK	1.60e-05	18	63	3	CID000007851
Drug	Cholecalciferol [67-97-0]; Up 200; 10.4uM; MCF7; HT_HG-U133A	IQCC HPGDS ETNK2 APC GGA1 CHRNB1	1.65e-05	195	63	6	3298_UP
Drug	AC1L1B7L	AOC2 AOC3	2.26e-05	3	63	2	CID000026477
Drug	3-aminopropionamide	AOC2 AOC3	2.26e-05	3	63	2	CID000192802
Drug	pentafluorobenzamide	AOC2 AOC3	2.26e-05	3	63	2	CID000069547
Drug	acisoga	AOC2 AOC3	2.26e-05	3	63	2	CID000129397
Drug	(+)-Cyanustine	AOC2 AOC3	2.26e-05	3	63	2	CID000028846
Drug	propylglyoxal	AOC2 AOC3	2.26e-05	3	63	2	CID000123249
Drug	3-Hydroxycadaverine	AOC2 AOC3	2.26e-05	3	63	2	CID000435285
Drug	5-fluoropentane-1,4-diamine	AOC2 AOC3	2.26e-05	3	63	2	CID010011890
Drug	NSD-1531	AOC2 AOC3	2.26e-05	3	63	2	CID003014318
Drug	Nazlinine	AOC2 AOC3	2.26e-05	3	63	2	CID000126237
Drug	5-aminopentanal	AOC2 AOC3	2.26e-05	3	63	2	CID000443849
Drug	necic acid	AOC2 AOC3	2.26e-05	3	63	2	CID006440847
Drug	AC1L34PU	AOC2 AOC3	2.26e-05	3	63	2	CID000134498
Drug	h202	AOC2 AOC3	2.26e-05	3	63	2	CID000013826
Drug	amicarbalide	AOC2 AOC3	2.26e-05	3	63	2	CID000072074
Drug	N-(4-aminobutyl)aziridine	AOC2 AOC3	2.26e-05	3	63	2	CID000152643
Drug	C10974	AOC2 AOC3	2.26e-05	3	63	2	CID000443042
Drug	alpha-difluoromethyl putrescine	AOC2 AOC3	2.26e-05	3	63	2	CID000135151
Drug	ketosuccinamate	AOC2 AOC3	2.26e-05	3	63	2	CID000439716
Drug	N-(3-aminopropyl)aziridine	AOC2 AOC3	2.26e-05	3	63	2	CID000014076
Drug	ethylmethylglyoxal bis(guanylhydrazone	AOC2 AOC3	2.26e-05	3	63	2	CID000129202
Drug	methylglyoxal bis(guanylhydrazone	ERCC2 AOC2 AOC3 CFB	2.47e-05	61	63	4	CID000009991
Drug	3-methyladenine	ERCC2 TP53INP1 PIK3C2G PIK3CB ALK	3.50e-05	134	63	5	CID000001673
Drug	baryta	ERCC2 AOC2 KCNJ16 AOC3 CFB	3.76e-05	136	63	5	CID000062392
Drug	plastoquinol-9	AOC2 FES CFB	3.92e-05	24	63	3	CID006440941
Drug	ICR-191	JAK1 ERCC2 PEX6	3.92e-05	24	63	3	CID000028240
Drug	malonamate	AOC2 AOC3	4.51e-05	4	63	2	CID000075367
Drug	2-aminoresorcinol	AOC2 AOC3	4.51e-05	4	63	2	CID000069450
Drug	Eovist (TN)	AOC2 AOC3	4.51e-05	4	63	2	CID009961939
Drug	AC1Q3E6A	AOC2 AOC3	4.51e-05	4	63	2	CID000068318
Drug	spermic acid	AOC2 AOC3	4.51e-05	4	63	2	CID000167029
Drug	N-acetyl-1,6-diaminohexane	AOC2 AOC3	4.51e-05	4	63	2	CID000162081
Drug	3-aminooxy-2-fluoro-1-propanamine	AOC2 AOC3	4.51e-05	4	63	2	CID000126496
Drug	2-Butene-1,4-diamine	AOC2 AOC3	4.51e-05	4	63	2	CID000148401
Drug	lanthionamine	AOC2 AOC3	4.51e-05	4	63	2	CID000070096
Drug	N-methylpyrrolinium	AOC2 AOC3	4.51e-05	4	63	2	CID000440932
Drug	dimethylpyridine	AOC2 AOC3	4.51e-05	4	63	2	CID000011420
Drug	1,4-diamino-2-butyne	AOC2 AOC3	4.51e-05	4	63	2	CID000124159
Drug	piperideine	AOC2 AOC3	7.50e-05	5	63	2	CID000068161
Drug	geranylamine	AOC2 AOC3	7.50e-05	5	63	2	CID000160248
Drug	allyl formate	STON1 AOC3	7.50e-05	5	63	2	CID000061278
Drug	phenamidine	AOC2 AOC3	7.50e-05	5	63	2	CID000064948
Drug	NSD 1039	AOC2 AOC3	7.50e-05	5	63	2	CID000193408
Drug	NSD 1024	AOC2 AOC3	7.50e-05	5	63	2	CID000188951
Drug	N(8)-(2-carboxyethyl)spermidine	AOC2 AOC3	7.50e-05	5	63	2	CID000125245
Drug	oxosparteine	AOC2 AOC3	7.50e-05	5	63	2	CID000097492
Drug	alpha-hydrazinohistidine	AOC2 AOC3	7.50e-05	5	63	2	CID000169499
Drug	perhydroazepinyl	AOC2 AOC3	7.50e-05	5	63	2	CID000123152
Drug	2-fluoroputrescine	AOC2 AOC3	7.50e-05	5	63	2	CID000147066
Drug	pelletierine	AOC2 AOC3	7.50e-05	5	63	2	CID000092987
Drug	1,4-diamino-2-butanone	AOC2 AOC3	7.50e-05	5	63	2	CID000151733
Drug	16 d	ERCC2 AOC2 AOC3	7.77e-05	30	63	3	CID000016401
Drug	AC1MBZ1C	CACNA1C PDE4A P2RY11 PIK3C2G PIK3CB SCG2 SYT1	9.47e-05	387	63	7	CID000003541
Drug	quinuclidinyl benzilate	AOC3 PZP CHRM5 CHRNB1	9.97e-05	87	63	4	CID000023056
Drug	NSC614854	AOC2 AOC3	1.12e-04	6	63	2	CID000122633
Drug	isothiouronium	AOC2 AOC3	1.12e-04	6	63	2	CID000031429
Drug	trihydroxyphenylalanine	AOC2 AOC3	1.12e-04	6	63	2	CID000591034
Drug	cyclohexanone oxime	AOC2 AOC3	1.12e-04	6	63	2	CID000007517
Drug	FF-705	AOC2 AOC3	1.12e-04	6	63	2	CID000126643
Drug	1,4-dimethylputrescine	AOC2 AOC3	1.12e-04	6	63	2	CID000162247
Drug	putreanine	AOC2 AOC3	1.57e-04	7	63	2	CID000161506
Drug	GYKI 11.121	AOC2 AOC3	1.57e-04	7	63	2	CID000193769
Drug	p-dimethylaminomethylbenzylamine	AOC2 AOC3	1.57e-04	7	63	2	CID000193714
Drug	2-hydrazinopyridine	AOC2 AOC3	1.57e-04	7	63	2	CID000078645
Drug	AC1L28PE	AOC2 AOC3	1.57e-04	7	63	2	CID000067954
Drug	tele-methylhistamine	TP53INP1 AOC2 AOC3	1.59e-04	38	63	3	CID000003614
Drug	Methimazole [60-56-0]; Up 200; 35uM; MCF7; HT_HG-U133A	RPAP1 SCG2 ZMYND8 APC BBS9	1.91e-04	192	63	5	3432_UP
Drug	Trimethadione [127-48-0]; Up 200; 28uM; MCF7; HT_HG-U133A	ERCC2 ZMYND8 GGA1 ALK CHRNB1	1.91e-04	192	63	5	2846_UP
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; PC3; HT_HG-U133A	ZMYND8 APC PCNX1 GGA1 BBS9	1.91e-04	192	63	5	6639_DN
Drug	orthovanadate	JAK1 PDE4A PIK3C2G PIK3CB AOC2 AOC3 DNAH1	1.95e-04	435	63	7	CID000061672
Drug	Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; PC3; HT_HG-U133A	NEK3 CRYBG2 ETNK2 ZMYND8 CHRNB1	1.96e-04	193	63	5	2055_UP
Drug	PF-01378883-00 [351320-41-7]; Up 200; 10uM; PC3; HT_HG-U133A	CRYBG2 ETNK2 APC SYT1 ALK	2.01e-04	194	63	5	6368_UP
Drug	Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; MCF7; HT_HG-U133A	CRYBG2 ERCC2 PDE4A MXRA5 CD5	2.01e-04	194	63	5	5610_UP
Drug	Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A	RPAP1 ZMYND8 APC GGA1 BBS9	2.01e-04	194	63	5	2864_DN
Drug	vanadyl	JAK1 PDE4A PIK3C2G PIK3CB FES DNAH1	2.04e-04	307	63	6	CID000061671
Drug	Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	IQCC ZMYND8 GGA1 BBS9 CHRNB1	2.06e-04	195	63	5	3282_UP
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A	STON1 PIK3CB APC SYT1 PCNX1	2.06e-04	195	63	5	6648_DN
Drug	Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ERCC2 STON1 RPAP1 IQCC APC	2.06e-04	195	63	5	4368_DN
Drug	Medina G	APC CRAMP1	2.09e-04	8	63	2	CID000171284
Drug	hyamine hydroxide	AOC2 AOC3	2.09e-04	8	63	2	CID000014842
Drug	1,2-diaminoguanidine	AOC2 AOC3	2.09e-04	8	63	2	CID000170039
Drug	NSC-356893	AOC2 AOC3	2.09e-04	8	63	2	CID000434770
Drug	Z H-H	AOC2 AOC3	2.09e-04	8	63	2	CID000004657
Drug	Q 192	AOC2 AOC3	2.09e-04	8	63	2	CID000077317
Disease	acquired metabolic disease (implicated_via_orthology)	IGF2BP3 IGF2BP2	2.52e-05	4	61	2	DOID:0060158 (implicated_via_orthology)
Disease	Schizophrenia	CACNA1C IGF2BP2 PDE4A HPGDS PIK3CB APC ZNF804A CHRM5 ALK	7.94e-05	883	61	9	C0036341
Disease	prostate cancer (is_implicated_in)	JAK1 ERCC2 PIK3CB APC	1.03e-04	117	61	4	DOID:10283 (is_implicated_in)
Disease	brain connectivity measurement	JAK1 STON1 KCNJ16 FES SYT1 NEDD4	1.77e-04	400	61	6	EFO_0005210
Disease	Dental enamel hypoplasia	SYT1 MAP3K21	2.74e-04	12	61	2	EFO_1001304
Disease	stomach cancer (is_implicated_in)	JAK1 ERCC2 APC	4.53e-04	72	61	3	DOID:10534 (is_implicated_in)
Disease	congenital myasthenic syndrome (implicated_via_orthology)	SYT1 CHRNB1	4.95e-04	16	61	2	DOID:3635 (implicated_via_orthology)
Disease	hepatocellular carcinoma (is_implicated_in)	JAK1 ERCC2 FES APC	5.44e-04	181	61	4	DOID:684 (is_implicated_in)
Disease	Glioma	PPM1D APC ALK	7.87e-04	87	61	3	C0017638
Disease	unipolar depression, schizophrenia	CACNA1C ZNF804A	1.22e-03	25	61	2	EFO_0003761, MONDO_0005090
Disease	macular degeneration (is_implicated_in)	ERCC2 CFB	1.43e-03	27	61	2	DOID:4448 (is_implicated_in)
Disease	Breast Cancer, Familial	PPM1D GEN1	1.76e-03	30	61	2	C0346153
Disease	white matter volume measurement	SYT1 ZNF804A	2.00e-03	32	61	2	EFO_0008320

Protein segments in the cluster

Peptide	Gene	Start	Entry
EPREHQPLPIQWKIQ	CD5	226	P06127
GQWEIIHKPSRLIQP	CHRNB1	206	P11230
HRVHSPNVRWLVQVP	AMPD2	561	Q01433
VPWSPEHQLQRLQVT	AOC3	551	Q16853
QAPHWSVRVRKAENP	RAB3GAP1	306	Q15042
VKEDNLVHWERPQRP	PZP	1181	P20742
QHAQPVNEKRFPTWR	IQCH	716	Q86VS3
LGIQWRHKPNVVSVE	JAK1	321	P23458
PSHEGQKKQRTIPWR	IQCC	421	Q4KMZ1
PETWVHRINFPLEIK	PIK3C2G	536	O75747
PEHWLQRPQLTRQVL	AOC2	551	O75106
HKQPWQAKISVIRPS	CFB	491	P00751
RKQRPWHPAVVFSVQ	P2RY11	56	Q96G91
VPPHVLVNWAVQVAR	MAP3K10	191	Q02779
INHNIKRTQWEDPRL	NEDD4	911	P46934
VQAIPAVANWIKRRP	HPGDS	181	O60760
IQELRPHWKPEQVRT	ETNK2	71	Q9NVF9
VTHYVLPQVRKQLPW	PCNX1	1306	Q96RV3
QHLWRQPRTPIRIQQ	PDE4A	31	P27815
QPHLARVQVLEPRWD	PEX6	236	Q13608
IRHRWGLPQKIQQSI	FAM205A	601	Q6ZU69
IQKQSIRHRWGLPQK	FAM205BP	326	Q63HN1
IRHRWGLPQKIQQSI	FAM205BP	331	Q63HN1
KWRLRVQHVVQESPP	ERCC2	341	P18074
QVRWEKQQPTPRLTL	GGA1	441	Q9UJY5
SRKIQIRNIPPHLQW	IGF2BP2	81	Q9Y6M1
VNRVVWKRPRLTHNG	PPM1D	241	O15297
IWIHPQPQRKSEGKV	PCDH11X	1031	Q9BZA7
RKLQIRNIPPHLQWE	IGF2BP3	81	O00425
KWATQLPHIPVAVRV	BBS9	321	Q3SYG4
PNLHRRQWEKNVPNT	NEK3	356	P51956
VEIPTHQPQRHWIKR	DNAH1	4241	Q9P2D7
RAIANVPPIQEKRHW	CRNKL1	516	Q9BZJ0
VWKPNHPERETVARL	IGSF3	856	O75054
VDHPIIQPRSWENSK	CACNA1C	1101	Q13936
EQKQVRLPESRLTPW	CCDC34	131	Q96HJ3
TWRQRPPTQEEIKHG	CRYBG2	21	Q8N1P7
VPIELQPRNNHAWAR	CRAMP1	321	Q96RY5
QQKPLPVSRWAQIHL	MAN2B1	666	O00754
LWQILEPVKQHIPLR	GEN1	6	Q17RS7
RQWVPQVQHKIDVIG	CLIP3	86	Q96DZ5
PNNAVIHNSWIDPKR	GPR22	396	Q99680
PRNKNWMNHLRVPQR	DLEC1	296	Q9Y238
LPKETAPAVQRVVWN	ZMYND8	806	Q9ULU4
VERDNWKRVSPLPLQ	KBTBD12	411	Q3ZCT8
NREPLVKIWHEIRTN	PARL	356	Q9H300
QLIPEVQKPLHEQLW	FES	446	P07332
ANPRRPIAQWHTLQV	SYT1	396	P21579
RIPPHVLVNWAVQIA	MAP3K21	231	Q5TCX8
NQLPKAAWIPHVENR	SCG2	476	P13521
PPKKTRIISHVWENN	PIK3CB	316	P42338
PVNHQPLERHRLWEV	CHRM5	16	P08912
PHTPQWQVRTLKDAR	ALK	496	Q9UM73
QSPSQNERWARPKHI	APC	1041	P25054
ANQVLEWVRAPPHVR	CHST14	306	Q8NCH0
ITEKWLPEIRTHNPQ	RHOV	121	Q96L33
KHPEQIFPRQRAIQW	MRPS9	126	P82933
PRIVNHWASPELRQN	SEC16A	306	O15027
DNIRIHFPVPSQWIK	STON1	566	Q9Y6Q2
AIRRNPDTQWITKPV	RPL15	141	P61313
PSQWIKEHSERQPLN	TP53INP1	191	Q96A56
WKDQQLHIEKAPPVR	KCNJ16	346	Q9NPI9
KLHWTQDLPPVRRQQ	RPAP1	336	Q9BWH6
WCIQDLHRQPVDPKR	VILL	396	O15195
VPVLNKHRSTVLQWP	ZNF804A	426	Q7Z570
EDRKTVWIHVNVQPP	MXRA5	2426	Q9NR99